Related Experiment Video

Updated: Jul 10, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

[Prevention of cardiovascular risk in diabetes]

Michel Marre1, Maria Duval-Leclercq, Florence Travert

  • 1Service d'endocrinologie-diabétologie-nutrition, groupe hospitalier Bichat-Claude-Bernard, Paris. michel.marre@bch.aphp.fr

La Revue Du Praticien
|November 21, 2007
PubMed

Insights

High blood glucose increases cardiovascular risk, even in non-diabetic individuals. Aggressive management of blood pressure, lipids, and anti-platelet therapy is crucial for type 2 diabetes patients.

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Medicine
  • Clinical Research

Context:

  • Elevated blood glucose levels, even below the diabetes threshold, are statistically linked to increased cardiovascular risk.
  • While causality is not definitively proven by clinical trials, microvascular protection is achieved with HbA1c below 7%.

Purpose:

  • To review the relationship between blood glucose, cardiovascular risk, and diabetes management strategies.
  • To emphasize the importance of non-glycemic interventions and risk factor control in type 2 diabetes.

Summary:

  • Cardiovascular risk is associated with rising blood glucose, independent of a diabetes diagnosis.
  • Achieving HbA1c <7% protects against microvascular complications, improving post-event prognosis if microcirculation is intact.
  • Aggressive management of non-glycemic risk factors (blood pressure, lipids, anti-platelet agents) is vital for type 2 diabetes patients, particularly those with microalbuminuria.

Impact:

  • Highlights the need for proactive cardiovascular risk management in individuals with elevated blood glucose.
  • Underscores the efficacy of multifactorial intervention strategies in type 2 diabetes.
  • Informs clinical practice regarding glycemic and non-glycemic targets for cardiovascular risk reduction.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...